Shares of Bio-Techne Corp. TECH rallied 2.14% to $52.04 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 0.11% ...
Shares of Bio-Techne Corp. TECH rose 1.01% to $52.00 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 1.15% to 6,581.00 and ...
CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as investors reacted to escalating uncertainty tied to the U.S.
[BRIEFING.COM] The S&PO 500 (+1.16%) is up 77 points this afternoon, good enough for second place. Meanwhile, Bio-Techne (TECH 48.73, -2.12, -4.17%) is one of today's worst laggards. Cookies are ...
13don MSN
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day
Shares of Charles River Laboratories International Inc. advanced 8.00% to $172.50 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index ...
Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. Its products assist scientific investigations ...
StockStory.org on MSN
Unpacking Q4 earnings: Thermo Fisher (NYSE:TMO) in the context of other research tools & consumables stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...
As the head of CBS News, Neeraj Khemlani kept looking for stories that would snare the interest of large crowds. Though he ...
New SPYRE™ Focus Panels (Stroma and Vessel) broaden modular panel options, enabling deeper targeted insights in spatial biology workflows. SPYRE™ Amplification Kits leverage sequential and enhanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results